List Title | APhA DrugInfoLine

Focus on Asthma Care

SORT BY: Most Recent Most Viewed

March 4, 2010

Conflicting data about genetics and beta-agonist therapy

READ

PREVIEW
Data analysis of 1,182 children suggests an association between an increased risk of asthma exacerbation with regular exposure to beta-agonist therapy and presence of arginine (Arg) at position...
January 1, 2010

Role of genetics and response to beta-agonist therapy

READ

PREVIEW
An analysis of data from 960 children with asthma showed that polymorphisms of the beta-2 adrenergic receptor gene (ADRB2) are associated with failure to respond to inhaled short-acting...
October 1, 2009

Optimistic drug message improves placebo effect in asthma

READ

PREVIEW
Results from a recently published study of more than 600 patients with poorly controlled asthma showed that placebo coupled with optimistic drug messaging resulted in improvements in self-...
September 1, 2009

Poor adherence to preventive asthma medication in teenagers

READ

PREVIEW
According to a recently published study in the Journal of Allergy and Clinical Immunology, adherence to fluticasone/salmeterol (Advair—GlaxoSmithKline) inhaler therapy was 43% in...
July 1, 2009

Characteristics of children likely to benefit from ICS use

READ

PREVIEW
Favorable outcomes with the use of an inhaled corticosteroid (ICS) in preschool children at risk for asthma were independently associated with greater disease severity, atopy, male sex, and...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.